Insights into stent implantation for coronary artery lesions caused by Kawasaki disease.
Tsuda E.
Cardiol Young. 2020 Jul;30(7):911-918. doi: 10.1017/S104795112000133X. Epub 2020 Jun 9.
PMID:32513335
Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation.
Hong SJ, Kim H, Ahn CM, Kim JS, Kim BK, Ko YG, Hong BK, Choi D, Jang Y, Hong MK.
Yonsei Med J. 2019 Sep;60(9):824-831. doi: 10.3349/ymj.2019.60.9.824.
PMID:31433580
Impact of Drug-Coated Balloon-Based Revascularization in Patients with Chronic Total Occlusions.
Shin ES, Her AY, Jang MH, Kim B, Kim S, Liew HB.
J Clin Med. 2024 Jun 9;13(12):3381. doi: 10.3390/jcm13123381.
PMID:38929910
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion.
Drug-coated balloons for coronary artery disease: current concepts and controversies.
Buccheri D, Lombardo RM, Cortese B.
Future Cardiol. 2019 Nov;15(6):437-454. doi: 10.2217/fca-2019-0009. Epub 2019 Nov 5.
PMID:31686536
Comparison of drug eluting stent implantation with coronary artery bypass surgery in the treatment of patients with chronic total occlusion and multiple vessel disease.
Liu W, Ma CS, Kang JP, Du X, Chen F, Zhou YJ, Lü SZ, Huang FJ, Gu CX, Zhu XL.
Chin Med J (Engl). 2011 Apr;124(8):1169-74.
PMID:21542990
Everolimus-eluting stents for treatment of chronic total coronary occlusions.